These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 26012162)
1. [Consensus statement of the Croatian Society for Nephrology, Dialysis and Transplantation regarding the use of generic immunosuppressive drugs]. Bašić-Jukić N; Rački S; Knotek M; Bubić-Filipi L; Bubić I; Zibar L; Kes P; Acta Med Croatica; 2014 Apr; 68(2):211-4. PubMed ID: 26012162 [TBL] [Abstract][Full Text] [Related]
2. Generic immunosuppression in solid organ transplantation: a Canadian perspective. Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158 [TBL] [Abstract][Full Text] [Related]
4. Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations. Spasovski G Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):133-8. PubMed ID: 27442379 [TBL] [Abstract][Full Text] [Related]
5. What Is the Future of Generics in Transplantation? van Gelder T Transplantation; 2015 Nov; 99(11):2269-73. PubMed ID: 26050017 [TBL] [Abstract][Full Text] [Related]
6. Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants. Alloway RR; Isaacs R; Lake K; Hoyer P; First R; Helderman H; Bunnapradist S; Leichtman A; Bennett MW; Tejani A; Takemoto SK Am J Transplant; 2003 Oct; 3(10):1211-5. PubMed ID: 14510694 [TBL] [Abstract][Full Text] [Related]
7. Generic tacrolimus in solid organ transplantation. Taube D; Jones G; O'Beirne J; Wennberg L; Connor A; Rasmussen A; Backman L Clin Transplant; 2014 May; 28(5):623-32. PubMed ID: 24750309 [TBL] [Abstract][Full Text] [Related]
8. Generic immunosuppression in transplantation: current evidence and controversial issues. El Hajj S; Kim M; Phillips K; Gabardi S Expert Rev Clin Immunol; 2015 May; 11(5):659-72. PubMed ID: 25817258 [TBL] [Abstract][Full Text] [Related]
9. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. Molnar AO; Fergusson D; Tsampalieros AK; Bennett A; Fergusson N; Ramsay T; Knoll GA BMJ; 2015 Jun; 350():h3163. PubMed ID: 26101226 [TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. Pollard S; Nashan B; Johnston A; Hoyer P; Belitsky P; Keown P; Helderman H; Clin Ther; 2003 Jun; 25(6):1654-69. PubMed ID: 12860490 [TBL] [Abstract][Full Text] [Related]
11. Generic formulation of mycophenolate mofetil (Myfenax) in de novo renal transplant recipients: results of 12-month observation. Rutkowski B; Bzoma B; Dębska-Ślizień A; Chamienia A Transplant Proc; 2014 Oct; 46(8):2683-8. PubMed ID: 25380894 [TBL] [Abstract][Full Text] [Related]
12. [The use of generics in transplantation: Towards rational and safe solutions!]. Rottembourg J; Rostoker G Presse Med; 2018 Mar; 47(3):199-210. PubMed ID: 29555162 [TBL] [Abstract][Full Text] [Related]
13. Generic Medicinal Products in Immunosuppressive Therapy-Should It be a Challenge for Therapeutic Drug Monitoring? Kocur A; Kunicki PK; Pawiński T Ther Drug Monit; 2023 Apr; 45(2):173-190. PubMed ID: 36920502 [TBL] [Abstract][Full Text] [Related]
14. Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products? Phillips K; Reddy P; Gabardi S J Pharm Pract; 2017 Feb; 30(1):9-16. PubMed ID: 26043743 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system. Spence MM; Nguyen LM; Hui RL; Chan J Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134 [TBL] [Abstract][Full Text] [Related]
16. Generic maintenance immunosuppression in solid organ transplant recipients. Ensor CR; Trofe-Clark J; Gabardi S; McDevitt-Potter LM; Shullo MA Pharmacotherapy; 2011 Nov; 31(11):1111-29. PubMed ID: 22026398 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients. Pamugas GE; Danguilan RA; Lamban AB; Mangati VB; Ona ET Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of anemia in chronic kidney disease--position statement of the Croatian Society for Nephrology, Dialysis and Transplantation and review of the KDIGO and ERPB guidelines]. Rački S; Bašić-Jukić N; Kes P; Ljutić D; Lovčić V; Prkačin I; Radić J; Vujičić B; Bubić I; Jakić M; Belavić Ž; Sefer S; Pehai M; Klarić D; Gulin M; Acta Med Croatica; 2014 Apr; 68(2):215-21. PubMed ID: 26012163 [TBL] [Abstract][Full Text] [Related]
19. Generics: are all immunosuppression agents created equally? Hauch A; John M; Smith A; Dortonne I; Patel U; Kandil E; Killackey M; Paramesh A; Lee B; Zhang R; Buell JF Surgery; 2015 Oct; 158(4):1049-54; discussion 1054-5. PubMed ID: 26206317 [TBL] [Abstract][Full Text] [Related]
20. Drug substitution in transplantation: a National Kidney Foundation White Paper. Sabatini S; Ferguson RM; Helderman JH; Hull AR; Kirkpatrick BS; Barr WH Am J Kidney Dis; 1999 Feb; 33(2):389-97. PubMed ID: 10023656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]